ArticleFrontiers in nutrition2025
Global, regional, and national burden of gallbladder and biliary tract cancer among adults aged 55 years and older, 2010-2021.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Rare Case of Squamous Cell Carcinoma of the Gallbladder Presenting as a Bleeding Colonic Mass.Cureus · 2026Article
- Burden of gallbladder and biliary tract cancer (GBTC) in the middle east and North Africa (MENA) from 1990 to 2021: from the global burden of disease (GBD).Annals of medicine and surgery (2012) · 2026Article
- Long-term effects of human development on the global burden of gallbladder and biliary tract cancer: a longitudinal multilevel analysis, 1990-2021.Gastroenterology and hepatology from bed to bench · 2026Article
- Global, regional, and national burden of gallbladder and biliary tract diseases: A systematic analysis of prevalence, incidence, deaths, and disability-adjusted life years with projections to 2050.Annals of hepato-biliary-pancreatic surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Gallbladder and Biliary Tract Cancer (GBTC) accounts for a notable proportion of cancer cases worldwide. This study aims to assess the burden of GBTC among aged 55 years and older, enhancing our understanding of its trends and their relationship with Socio-Demographic Index (SDI) across regions and countries. Methods: We used the data from the Global Burden of Disease study from 2010 to 2021 to analyze GBTC incidence, death numbers, disability-adjusted life years (DALYs) and their respective rates for individuals aged 55 years and older. We also reported the GBTC percentage trend during this period. Results: The global incidence and death cases of GBTC changed significantly between 2010 and 2021. Compared to 2010, GBTC incidence and deaths increased by 35.9% and 29.7% individually in 2021. High-income Asia Pacific was the region with the highest age-standardized incidence, deaths, and DALYs in 2021, and China was the country with the largest number of incidence cases, deaths, and DALYs in 2021. Furthermore, the highest age-standardized incidence rate and age-standardized death rate occurred in Japan. Among individuals aged 55 years and older, the highest incident and death cases were observed in 70-74 age group, and females were more suffered from GBTC than males between 2010 and 2021. Conclusion: GBTC remains a substantial and growing global health burden, particularly among females and the aged from 2010 to 2021. The absolute number of GBTC cases continued to rise over the past decade in aged 55 years and older.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.